MNOV - MediciNova, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development3,519.1723,017.1693,259.694
Selling General and Administrative7,362.6625,805.2175,963.317
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-10,881.834-8,822.386-9,223.011
Income from Continuing Operations
Total Other Income/Expenses Net20.063-14.8224.375
Earnings Before Interest and Taxes-10,861.771-8,837.206-9,198.636
Interest Expense0.4540.5140.628
Income Before Tax-10,862.225-8,837.72-9,199.264
Income Tax Expense3.7547.359-3.972
Minority Interest---
Net Income From Continuing Ops-10,865.979-8,845.079-9,195.292
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,865.979-8,845.079-9,195.292
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,865.979-8,845.079-9,195.292